← Open Payments lookup

NARE ARSHAKYAN: Open Payments

NPI 1609400605 · GLENDALE, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$704 in 29 payments from 12 companies in 2025. Trend: 2023 $1,365 · 2024 $1,474 · 2025 $704

Food & beverage: $704
CompanyPaymentsAmount
Genentech USA, Inc.4$125
Lilly USA, LLC4$110
ABBVIE INC.5$96
Lundbeck LLC5$86
Novartis Pharmaceuticals Corporation2$69
Neurelis, Inc.2$47
Alexion Pharmaceuticals, Inc.2$43
Amgen Inc.1$34
Phathom Pharmaceuticals, Inc.1$25
Esperion Therapeutics, Inc.1$24

Products named: Ocrevus Zunovo, VYEPTI, KESIMPTA, KISUNLA, QULIPTA, VALTOCO, ULTOMIRIS, EVENITY.

Industry payments across CA — which companies pay providers there.